# Stramsen Biotech, Inc. — Regulation A 1-A

Stramsen Biotech, Inc. of Houston, TX filed a Regulation A 1-A with the SEC on 2024-11-06. Aggregate offering: $20.0M (Tier 1). Industry: Other.

## Offering

- Filed: 2024-11-06
- Form: 1-A
- Accession: 0001099910-24-000364
- Tier: Tier 1
- Total aggregate offering: $20.0M
- Issuer portion: $20.0M
- Price per security: $1.2000
- Securities offered: Equity (common or preferred stock)
- Audit status: Unaudited
- Jurisdictions: 52 states/territories

## Issuer

- CIK: 0001943948
- Organized in: DE
- Incorporated: 2020
- Address: 5718 Westheimer Rd, Houston, TX, 77057
- Phone: 713-955-1156
- Employees: 20 full-time

## Financial snapshot (as filed)

- Total assets: $23K
- Cash & equivalents: $350
- Total liabilities: $57K
- Stockholder equity: $-34K
- Net income: $-110K

## People (1)

| Name | Role | Location |
| --- | --- | --- |
| Scott Villwock | Signer | Houston, TX |

## More

- [CIK 1943948 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1943948&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/rega/0001099910-24-000364.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.